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We present a rare case of extramedullary plasmacytoma of the palatine tonsil with cervical lymph node involvement treated by
surgical resection. A 58-year-old Caucasian male presented with a solitary 3cm × 3cm jugulodigastric lymph node and was found
to have an ipsilateral tonsillar swelling. The involved tonsil and lymph node were surgically resected after two inconclusive ﬁne-
needle aspirates, and plasmacytoma was conﬁrmed histologically and by immunocytochemistry. Adjuvant radiotherapy was not
indicated as adequate resection was achieved at surgery. We also highlight the challenges of diagnosis when ﬁne-needle aspiration
is inconclusive and the need for careful planning before surgery.
1.Introduction
Extramedullary plasmacytomas are rare tumours which
usuallyoccurintheupperaerodigestivetract;itisevenmuch
rarer for them to originate from the tonsil. It is important to
exclude systemic myeloma or multilesional disease in these
patients. Long-term monitoring is mandatory to detect early
local recurrence or conversion to multiple myeloma.
2. Case Presentation
A 58-year-old Caucasian male was referred to the otolaryn-
gology outpatient clinic from the oncology department with
a complaint of a right-upper neck mass which had been
growing for one year. The mass was painless and had rapidly
increased in size during the preceding 3 months. The patient
reported no loss of weight and had no other masses. He
denied swallowing or breathing diﬃculties. There was no
history of exposure to tuberculosis. He was a farmer and life-
long nonsmoker. On physical examination, he was a well-
nourished man with a palpable, freely mobile nontender
rightlevelIIlymphnodemeasuring3cm×3cm.Oropharyn-
geal examination showed a moderately enlarged right tonsil.
The rest of the physical examination was unremarkable.
Rigid direct laryngoscopy showed a normal laryngopharynx
and hypopharynx.
Due to a possible vascular relation to the mass, an MRI
of the neck was done, showing a sharply deﬁned ovoid 3 ×
3 × 4.5cm nonspeciﬁc soft tissue mass with heterogeneous
enhancement, likely a lymph node, with a mass-like bulge
in the right tonsillar fossa suspicious for a primary tumour
(Figure 1). This supported the clinical diagnosis of a tonsillar
primary lesion with a regional nodal deposit.
Two previous ﬁne-needle aspirates (FNAs) of the neck
mass had already been undertaken by the oncologists, but
these were inconclusive. The aspirates were heavily blood
stained and showed small tissue fragments composed of
small lymphoid cells admixed with histiocytes. The sparse
material suggested an inﬂammatory/reactive process, and
ﬂow cytometry was nondiagnostic. Therefore an excision
biopsy with frozen sections was recommended for deﬁnitive
diagnosis. If this revealed a squamous cell carcinoma, the2 International Journal of Otolaryngology
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Figure 1: MRI of the neck showing an enlarged lymph node
(long arrow) and a bulge in the right tonsillar fossa (short arrow)
suspicious for primary tumour.
Figure 2 :L y m p hn o d ew i t hd i ﬀuse inﬁltrate of plasma cells
including atypical binucleated and multinucleated forms (black
arrows) (H & E stain, x40).
operation would proceed to a selective neck dissection. The
patient consented to the procedure and underwent a right
tonsillectomy and excision of the enlarged lymph node.
Frozen sections suggested a plasmacytoma and therefore a
neck dissection was not carried out.
Histologies of both the tonsillar mass and the lymph
node were similar, showing eﬀacement of normal archi-
tecture and extensive inﬁltration with diﬀuse sheets of
neoplastic cells possessing plasmacytoid morphology with
eccentric nuclei exhibiting “clock-faced” nuclear chromatin
pattern that typically represent plasma cells. Binucleate
and multinucleate forms were also present (Figure 2). The
tonsillar lesion was fairly circumscribed and the epithelium
was not inﬁltrated (Figure 3).
Furtherimmunohistochemicalanalysisonthespecimens
showed CD138 plasma cell marker positivity (Figure 4),
while CD20 and CD3 were negative, with kappa light chain
restriction. This proﬁle was in keeping with plasmacy-
toma. Serum protein electrophoresis showed the presence
Figure 3: Tonsillar tissue with intact surface squamous epithelium
(arrow) and underlying diﬀuse inﬁltrate of neoplastic plasma cells
(H & E stain, x10).
Figure 4: CD138 immunostain was positive, conﬁrming plasma
cells (x40).
of monoclonal IgG kappa with normal levels of residual
immunoglobulins. Skeletal survey, bone marrow biopsy,
serum-free light chain, and urine analysis for Bence-Jones
protein showed normal results.
Six months after surgery the patient remained well.
Repeat immunoglobulin assay at the 3-month postoperative
review showed that the monoclonal IgG had returned to
normal levels, with normal light chains and no evidence
of multiple myeloma on bone marrow biopsy and no lytic
lesions on skeletal survey. Repeat investigations at the 6-
month mark remained negative.
3. Discussion
Plasmacytomas are malignant proliferations of plasma cells
that occur either in bone (medullary) or in soft tissue
(extramedullary). Medullary or extramedullary disease may
present as either solitary or multiple lesions. The systemic
disease involving multiple lesions in bones (called multiple
myeloma) is the commonest plasma cell dyscrasia, account-
ing for over 90% of all plasma cell malignancies.
The exact incidence of extramedullary plasmacytomas
(EMP) is unknown, but they are rare, accounting for only
3%-4% of all plasma cell malignancies [1, 2]. It is estimatedInternational Journal of Otolaryngology 3
that 80%–90% of EMP develop in the head and neck region
[2–4]. There are no identiﬁable risk factors. In an extensive
retrospective study of reported cases between 1905 and
1997, Alexiou et al. [2] found that 82.2% of cases of EMP
occurred in the upper aerodigestive (UAD) tract, with 10.5%
involving the tonsil or soft palate. They also found that the
most common areas of the UAD aﬀected were the nasal
cavityorparanasalsinuses(43%),nasopharynx(18.3%),and
oropharynx(17.8%).NodalinvolvementofEMPintheUAD
w a sr e p o r t e di no n l y7 . 6 %o fc a s e s[ 2].
EMP of the tonsil usually presents as a unilateral tonsillar
swelling, but at least one case of bilateral involvement of
the palatine tonsil has been reported [5]. Evaluation of the
patient begins with a full history and clinical examination,
including oral examination and nasopharyngoscopy.
FNA may provide inconclusive results as it is sometimes
diﬃcult to distinguish inﬂammatory or reactive conditions
fromevolving tumours. However, FNA may be usefulin SCC
or recurrent EMP, especially if used in conjunction with a
core biopsy and subsequent immunocytochemistry [6, 7].
Imaging studies such as computer tomographic (CT)
scanning, magnetic resonance imaging (MRI), and positron
emissiontomographic(PET)scanningusuallyprovideuseful
information on the extent of local disease. Anatomical
localization is enhanced with integrated PET/CT scanning,
especially when localising EMPs outside the head region
where it is proven to be more sensitive than MRI [8].
Preferably all patients should be referred to a hema-
tologist for further workup to exclude multiple myeloma
or disseminated disease. Baseline full blood examination,
serumcalcium,urea,andelectrolytesshouldbeperformedin
addition to serum protein electrophoresis and immunoﬁxa-
tion, urine Bence-Jones proteins, skeletal survey, and bone
marrow examination. The abnormal plasma cells of EMPs
originate from one cell line and all produce the same
immunoglobulin, usually an IgG kappa light chain. In some
patients this can be detected as a small monoclonal peak on
immunoelectrophoresis called the M spike. With successful
eradication of disease, the M spike disappears and this can be
demonstrated on subsequent followup.
Solitary EMP is managed with radiotherapy, surgery,
or both. If a complete surgical resection is achieved, then
no adjuvant radiotherapy is required as in our case [8].
However, regardless of whichever option is used, regular
monitoring is warranted as the risks of local recurrence
and development of multiple myeloma still exist and can
occur many years after treatment of the initial tumour. In
retrospective, nonrandomised studies, local recurrence was
observed in 22% of cases [2].
We recommend reviews at 3 monthly intervals for the
ﬁrstyear,6monthlyforanotheryear,andyearlythereafterfor
life. At each visit, in addition to a history and physical exami-
nation, laboratory testing including complete blood count,
urea, creatinine and electrolytes, immunoelectrophoresis,
and free light chains should be performed. This will be in
addition to yearly monitoring with MRI (which was our
initial imaging modality). At any hint of recurrence such as
new M spike, a full reevaluation is required including bone
marrow biopsy and an integrated CT/PET.
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